Sentante takes physical AI to market, beginning commercial rollout in vascular surgery and interventional radiology

<p>Following its May 2026 CE mark, Sentante is deploying first in the specialties its platform was built to serve, and where the multi-modal data that trains endovascular physical AI accumulates from the first commercial case KAUNAS, Lithuania, Aug. 25, 2026 /PRNewswire/ -- Sentante, the...</p>